喵ID:hl1wF8免责声明

Ophthalmic Product Development: From Bench to Bedside

眼科产品开发:从实验室到临床

基本信息

DOI:
10.1007/978-3-030-76367-1
发表时间:
2021
期刊:
Ophthalmic Product Development
影响因子:
--
通讯作者:
Nigel K. H. Slater
中科院分区:
文献类型:
--
作者: Seshadri Neervannan;Uday B. Kompella;Patrick M. Hughes;Jie Shen;S. P. Srinivas;Giovanna Guidoboni;A. Burli;Bhavya Harjai;Clive G. Wilson;Imran Ahmed;Wanachat Chaiyasan;Riccardo Sacco;Abhishek Anand;Hemant Amreen H. Siraj;Kumar Daima;Anuradha Gore;Chetan P. Pujara;Ayako Hasegawa;Melissa Gulmezian;Ying Cheng;Ramakrishnan Srikumar;Seungyil Yoon;M. Regn;H. Gukasyan;R. Graham;V. Agrahari;Onkar N. Singh;Frédéric Lallemand;J. Garrigue;V. Andrés;I. Molina;I. Bravo;R. Herrero;E. Sánchez;E. Souto;M. Espina;A. Cano;M. Ettcheto;Antoni Camins;M. L. García;Hu Yang;Gitanjali Sharma;Chen Zhou;S. Wadhwa;A. Parenky;Kenneth S. Graham;Amardeep S. Bhalla;Dingjiang Liu;Hunter H. Chen;Mohammed Shameem;Susan Lee;Laszlo Romoda;Michael Robinson;Peter A. Simmons;Stephanie H. Choi;Yan Wang;Darby Kozak;J. Michael;Gerard A. Rodrigues;Evgenyi Shalaev;Thomas K. Karami;James Cunningham;Hongwen M. Rivers;Shaoxin Feng;Dinen Shah;Nigel K. H. Slater研究方向: -- MeSH主题词: --
关键词: --
来源链接:pubmed详情页地址

文献摘要

Ocular applications have a fascinating history from the time of various ancient civilizations. From the first known written record of medical treatment of eye diseases dating back to 1500 BCE to the current amazing array of products including gene and cell therapy treatments, ophthalmic products have reached a point where no segment of the eye is ignored and curing blindness is in the horizon. An increase in the aging population has increased the prevalence of age-related ocular conditions that are difficult to treat, and the treatments are still evolving. Regulations and science are converging around the world, and with the increasing access to information, many new innovative products are in the works that will significantly alter the treatment of ophthalmic conditions in the years and decades to come.
从各个古代文明时期起,眼科应用就有着一段迷人的历史。从公元前1500年已知的最早关于眼部疾病治疗的书面记录,到如今包括基因和细胞疗法等令人惊叹的一系列产品,眼科产品已经发展到眼部的任何部位都不会被忽视,治愈失明也即将成为可能。老龄人口的增加使得难以治疗的与年龄相关的眼部疾病更为普遍,而且治疗方法仍在不断发展。世界各地的法规和科学正在趋于一致,并且随着信息获取途径的增多,许多创新产品正在研发中,这将在未来数年乃至数十年显著改变眼科疾病的治疗方式。
参考文献(2)
被引文献(2)
Topical ocular drug delivery: recent developments and future challenges.
DOI:
10.1089/jop.1986.2.67
发表时间:
1986-01-01
期刊:
Journal of ocular pharmacology
影响因子:
0
作者:
Lee, V H;Robinson, J R
通讯作者:
Robinson, J R

数据更新时间:{{ references.updateTime }}

Nigel K. H. Slater
通讯地址:
--
所属机构:
--
电子邮件地址:
--
免责声明免责声明
1、猫眼课题宝专注于为科研工作者提供省时、高效的文献资源检索和预览服务;
2、网站中的文献信息均来自公开、合规、透明的互联网文献查询网站,可以通过页面中的“来源链接”跳转数据网站。
3、在猫眼课题宝点击“求助全文”按钮,发布文献应助需求时求助者需要支付50喵币作为应助成功后的答谢给应助者,发送到用助者账户中。若文献求助失败支付的50喵币将退还至求助者账户中。所支付的喵币仅作为答谢,而不是作为文献的“购买”费用,平台也不从中收取任何费用,
4、特别提醒用户通过求助获得的文献原文仅用户个人学习使用,不得用于商业用途,否则一切风险由用户本人承担;
5、本平台尊重知识产权,如果权利所有者认为平台内容侵犯了其合法权益,可以通过本平台提供的版权投诉渠道提出投诉。一经核实,我们将立即采取措施删除/下架/断链等措施。
我已知晓